홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Hydrochloric Acid → HCID 178502488, 화합물

HRID 625663
노트
인쇄 미리보기

반응식

HRID 625663 반응식
Cl.[C:2]([OH:8])([C:4](F)(F)F)=O.[CH3:9][O:10][C:11]([NH:13][C@@H:14]([CH:58]([CH3:60])[CH3:59])[C:15]([N:17]1[C@H:22]([C:23]2[NH:24][C:25]([C:28]#[C:29][C:30]3[CH:31]=[C:32]4[C:37](=[CH:38][CH:39]=3)[CH:36]=[C:35]([C:40]3[NH:44][C:43]([C@@H:45]5[CH2:50][C@@H:49]6[C@@H:47]([CH2:48]6)[N:46]5C(OC(C)(C)C)=O)=[N:42][CH:41]=3)[CH:34]=[CH:33]4)=[CH:26][N:27]=2)[CH2:21][C@@H:20]2[C@H:18]1[CH2:19]2)=[O:16])=[O:12].[CH3:61][O:62][C:63]([NH:65][C@@H:66]([C@@H:70]1[CH2:75]CCO[CH2:71]1)[C:67]([OH:69])=O)=[O:64].CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>O1CCOCC1.CN(C=O)C>[CH3:9][O:10][C:11]([NH:13][C@@H:14]([CH:58]([CH3:60])[CH3:59])[C:15]([N:17]1[C@H:22]([C:23]2[NH:27][CH:26]=[C:25]([C:28]#[C:29][C:30]3[CH:31]=[C:32]4[C:37](=[CH:38][CH:39]=3)[CH:36]=[C:35]([C:40]3[N:44]=[C:43]([C@@H:45]5[CH2:50][C@@H:49]6[C@@H:47]([CH2:48]6)[N:46]5[C:67](=[O:69])[C@@H:66]([NH:65][C:63](=[O:64])[O:62][CH3:61])[C@@H:70]5[CH2:71][CH2:4][CH2:2][O:8][CH2:75]5)[NH:42][CH:41]=3)[CH:34]=[CH:33]4)[N:24]=2)[CH2:21][C@@H:20]2[C@H:18]1[CH2:19]2)=[O:16])=[O:12]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 6

HCID 313Hydrochloric AcidHCID 6422Trifluoroacetic acidHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 58498834(S)-2-((Methoxycarbonyl)amino)-2-((S)-tetrahydro-2H-pyran-3-yl)acetic acid
HCID 58498864
(1R,3S,5R)-tert-butyl 3-(5-(6-((2-((1R,3S,5R)-2-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-2-azabicyclo[3.1.0]hexan-3-yl)-1H-imidazol-5-yl)ethynyl)naphthalen-2-yl)-1H-imidazol-2-yl)-2-azabicyclo[3.1.0]hexane-2-carboxylate
2회

생성물 1

HCID 178502488HCID 178502488, 화합물

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 312751,4-Dioxane용매2회

실험 절차

4M HCl (0.3 mL, 1.3 mmol) in dioxane was added to mixture of a TFA salt of (1R,3S,5R)-tert-butyl 3-(5-(6-((2-((1R,3S,5R)-2-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-2-azabicyclo[3.1.0]hexan-3-yl)-1H-imidazol-5-yl)ethynyl)naphthalen-2-yl)-1H-imidazol-2-yl)-2-azabicyclo[3.1.0]hexane-2-carboxylate (Intermediate 158) (60 mg, 0.064 mmol) in dioxane (0.5 mL) and the reaction was stirred vigorously for 4 h. The reaction was concentrated to dryness. Then (S)-2-(methoxycarbonylamino)-2-((S)-tetrahydro-2H-pyran-3-yl)acetic acid (Cap-177a) (18.2 mg, 0.084 mmol), DMF (0.5 mL), DIPEA (0.067 mL, 0.39 mmol) and finally HATU (32 mg, 0.084 mmol) was added to the crude material and the reaction was stirred at rt for 1 h. The reaction was partially concentrated, diluted with MeOH, filtered and purified by preparative HPLC (MeOH/water with a TFA buffer) and repurified in one injection by Prep HPLC (MeOH/water with an ammonium acetate buffer) to yield methyl ((1S)-2-((1R,3S,5R)-3-(4-(6-((2-((1R,3S,5R)-2-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-azabicyclo[3.1.0]hex-3-yl)-1H-imidazol-4-yl)ethynyl)-2-naphthyl)-1H-imidazol-2-yl)-2-azabicyclo[3.1.0]hex-2-yl)-2-oxo-1-((3S)-tetrahydro-2H-pyran-3-yl)ethyl)carbamate (30.5 mg) as a white solid. LC-MS retention time 3.376 min; m/z 803.66 (MH+). LC data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped with a PHENOMENEX® Luna 3u C18 2.0×50 mm column using a SPD-10AV UV-Vis detector at a detector wave length of 220 nM. The elution conditions employed a flow rate of 0.8 mL/min, a gradient of 100% Solvent A/0% Solvent B to 0% Solvent A/100% Solvent B, a gradient time of 4 min, a hold time of 1 min, and an analysis time of 5 min where Solvent A was 10% MeOH/90% H2O/0.1% trifluoroacetic acid and Solvent B was 10% H2O/90% MeOH/0.1% trifluoroacetic acid. MS data was determined using a MICROMASS® Platform for LC in electrospray mode. 1H NMR (400 MHz, MeOD) δ ppm 8.14 (s, 1H), 7.94 (s, 1H), 7.78-7.86 (m, 3H), 7.49 (dd, J=8.5, 1.5 Hz, 1H), 7.45 (s, 1H), 7.26 (s, 1H), 5.15 (ddd, J=12.9, 8.7, 4.5 Hz, 2H), 4.57 (d, J=6.8 Hz, 1H), 3.70-3.86 (m, 3H), 3.67 (br. s., 3H), 3.66 (br. s., 3H), 3.58-3.64 (m, 1H), 3.53 (t, J=8.3 Hz, 1H), 3.45 (dd, J=11.4, 8.2 Hz, 1H), 2.31-2.57 (m, 4H), 1.93-2.17 (m, 5H), 1.67-1.84 (m, 2H), 1.50-1.63 (m, 2H), 1.08-1.17 (m, 2H), 0.98 (d, J=6.8 Hz, 3H), 0.92 (d, J=6.8 Hz, 3H), 0.78 (br. s., 2H).

후처리

  1. concentrationThe reaction was concentrated to dryness
  2. stirringthe reaction was stirred at rt for 1 h
  3. concentrationThe reaction was partially concentrated
  4. additiondiluted with MeOH
  5. filtrationfiltered
  6. custompurified by preparative HPLC (MeOH/water with a TFA buffer) and
  7. customrepurified in one injection by Prep HPLC (MeOH/water with an ammonium acetate buffer)

출처 및 근거

ORD 기록
ord-bf5c57f8eb004574a5e61376dddee0de
출처 데이터셋
uspto-grants-2016_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09303007B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트